✦ LIBER ✦

TPDM2: COST-EFFECTIVENESS OF INCREASING WARFARIN USAGE FOR STROKE PROPHYLAXIS IN PATIENTS WITH ATRIAL FIBRILLATION

✍ Scribed by DR Touchette; PJ Keys; E Racine; RM Massanari; J Andersen; J Stevenson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COST-EFFECTIVENESS OF RIVAROXABAN COMPAR

✍ Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Use of resources and cost implications o

✍ Ahmed H. Abdelhafiz; Nigel M Wheeldon 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 768 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

Cost–Effectiveness of Clopidogrel Plus A

✍ Craig I. Coleman; Andrew D. Straznitskas; Diana M. Sobieraj; Jeffrey Kluger; Moi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 615 KB